Ignite Creation Date:
2025-12-24 @ 11:35 PM
Ignite Modification Date:
2026-01-05 @ 6:20 PM
Study NCT ID:
NCT00615056
Status:
COMPLETED
Last Update Posted:
2013-04-19
First Post:
2008-02-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study Combining FOLFOX or FOLFIRI With AG-013736 or Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer After Failure Of One First Line Regimen
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-03
Start Date Type:
None
Primary Completion Date:
2011-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-04
Completion Date Type:
ACTUAL
First Submit Date:
2008-02-01
First Submit QC Date:
None
Study First Post Date:
2008-02-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-03-28
Results First Submit QC Date:
None
Results First Post Date:
2012-04-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-04-12
Last Update Post Date:
2013-04-19
Last Update Post Date Type:
ESTIMATED